ID   iPS-SCU-CD34+ #1
AC   CVCL_V199
SY   CB-CD34+ iPSC1
DR   Wikidata; Q54898130
RX   PubMed=20641038;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Linea_iPS%2520SCU%2520CD34-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_iPS%2520CSU%2520CD34%2520-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Andalusian Stem Cell Bank; Granada; Spain.
CC   HLA typing: A*02:01,24:02; B*51:01,51:01; C*14:02,16:02; DQB1*06:02,06:03; DRB1*13:01,15:01 (BNLC).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V200 ! iPS-SCU-CD34+ #2
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
RX   PubMed=20641038; DOI=10.1002/stem.471; PMCID=PMC2996086;
RA   Gutierrez-Aranda, Ivan
RA   Ramos-Mejia, Veronica
RA   Bueno, Clara
RA   Munoz-Lopez, Martin
RA   Real, Pedro J.
RA   Macia, Angela
RA   Sanchez, Laura
RA   Ligero, Gertrudis
RA   Garcia-Parez, Jose L.
RA   Menendez, Pablo
RT   "Human induced pluripotent stem cells develop teratoma more
RT   efficiently and faster than human embryonic stem cells regardless the
RT   site of injection.";
RL   Stem Cells 28:1568-1570(2010).
//